We are joined by Dr Halis Akturk at the ADA annual meeting to discuss the topic of his two presentations, the advantages and limitations of closed-loop systems in patients with type 1 diabetes.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA
1. Could you tell us a little about hybrid closed-loop systems and their advantages? (0:05)
2. What were the findings of your study of hybrid closed-loop system in patients with type 1 diabetes? (0:33)
3. What are the current limitations of this system and how may they be overcome? (1:52)
4. What have we learned about the association between immune checkpoint inhibitors and type 1 diabetes? (2:49)
5. Which patients are at highest risk of checkpoint-inhibitor induced diabetes? (4:37)
Halis Akturk has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022
We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research highlights in diabetes and what to look out for in 2023. Questions What are the key clinical highlights from 2022 in the field of diabetes? (0:16) What are the hot topics and […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!